R13HL179935
Project Grant
Overview
Grant Description
2025 Molecular and Cellular Biology of Lipids Gordon Research Conference and Gordon Research Seminar - Lipids play a pivotal role in nearly all aspects of cellular function, including cell membrane construction, energy metabolism, hormone synthesis, nutrient transport, and regulation of the inflammatory response.
Underscoring their importance, perturbation of lipid metabolism leads to cardiovascular disease, metabolic syndrome, obesity, and numerous other disorders that constitute a key focus of the NHLBI mission.
Innovative research to elucidate the unique functions of lipids and mechanisms that regulate their synthesis will continue to discover new pathological mechanisms and potential treatments for these disorders.
The Molecular and Cellular Biology of Lipids (MCBL) Gordon Research Conference continues to be the premier meeting in the lipid research field.
It provides a forum for networking, collaboration, and the dissemination of new, predominantly unpublished research findings and breakthrough analytical tools in the fields of lipid biology, biochemistry, and biophysics.
The 2025 MCBL Gordon Conference will place a particular focus on “Re-envisioning the fluid mosaic model of membrane-lipid interactions with cutting edge approaches.”
The fluid mosaic model revolutionized our understanding of membrane-lipid interactions when it was proposed about 50 years ago.
While the fundamental structure proposed by this model remains valid, re-envisioning the model in light of the wealth of knowledge made possible by new analytical tools is essential to advance our understanding of the role of membrane lipids in cellular function.
The 2025 MCBL will incorporate and build on the major successful strategies of previous meetings to explore this unique focus.
The specific aims of this meeting are to: 1) Present unpublished exciting interdisciplinary data that highlight emerging concepts and hypotheses in lipid research; 2) Disseminate knowledge about cutting-edge tools and approaches; and 3) Provide an exciting environment that encourages the free exchange of ideas among researchers at all career levels.
The anticipated impact of this meeting will be: 1) The dissemination of the latest discoveries that fine-tune the fluid-mosaic model and the exciting new approaches that will continue to advance lipid research, and 2) The generation of new relationships and collaborations among junior and senior scientists that fulfill the NHLBI mission to further develop, and sustain a scientific workforce committed to lipid research.
Underscoring their importance, perturbation of lipid metabolism leads to cardiovascular disease, metabolic syndrome, obesity, and numerous other disorders that constitute a key focus of the NHLBI mission.
Innovative research to elucidate the unique functions of lipids and mechanisms that regulate their synthesis will continue to discover new pathological mechanisms and potential treatments for these disorders.
The Molecular and Cellular Biology of Lipids (MCBL) Gordon Research Conference continues to be the premier meeting in the lipid research field.
It provides a forum for networking, collaboration, and the dissemination of new, predominantly unpublished research findings and breakthrough analytical tools in the fields of lipid biology, biochemistry, and biophysics.
The 2025 MCBL Gordon Conference will place a particular focus on “Re-envisioning the fluid mosaic model of membrane-lipid interactions with cutting edge approaches.”
The fluid mosaic model revolutionized our understanding of membrane-lipid interactions when it was proposed about 50 years ago.
While the fundamental structure proposed by this model remains valid, re-envisioning the model in light of the wealth of knowledge made possible by new analytical tools is essential to advance our understanding of the role of membrane lipids in cellular function.
The 2025 MCBL will incorporate and build on the major successful strategies of previous meetings to explore this unique focus.
The specific aims of this meeting are to: 1) Present unpublished exciting interdisciplinary data that highlight emerging concepts and hypotheses in lipid research; 2) Disseminate knowledge about cutting-edge tools and approaches; and 3) Provide an exciting environment that encourages the free exchange of ideas among researchers at all career levels.
The anticipated impact of this meeting will be: 1) The dissemination of the latest discoveries that fine-tune the fluid-mosaic model and the exciting new approaches that will continue to advance lipid research, and 2) The generation of new relationships and collaborations among junior and senior scientists that fulfill the NHLBI mission to further develop, and sustain a scientific workforce committed to lipid research.
Awardee
Funding Goals
TO FOSTER HEART AND VASCULAR RESEARCH IN THE BASIC, TRANSLATIONAL, CLINICAL AND POPULATION SCIENCES, AND TO FOSTER TRAINING TO BUILD TALENTED YOUNG INVESTIGATORS IN THESE AREAS, FUNDED THROUGH COMPETITIVE RESEARCH TRAINING GRANTS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, USE SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, FOSTER AND ENCOURAGE PARTICIPATION IN INNOVATION AND ENTREPRENEURSHIP BY SOCIALLY AND ECONOMICALLY DISADVANTAGED PERSONS, AND INCREASE PRIVATE-SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT FUNDING. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, FOSTER TECHNOLOGY TRANSFER THROUGH COOPERATIVE R&D BETWEEN SMALL BUSINESSES AND RESEARCH INSTITUTIONS, AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL R&D.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
East Greenwich,
Rhode Island
028183465
United States
Geographic Scope
Single Zip Code
Gordon Research Conferences was awarded
Project Grant R13HL179935
worth $34,325
from National Heart Lung and Blood Institute in July 2025 with work to be completed primarily in East Greenwich Rhode Island United States.
The grant
has a duration of 1 year and
was awarded through assistance program 93.837 Cardiovascular Diseases Research.
The Project Grant was awarded through grant opportunity NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 7/25/25
Period of Performance
7/20/25
Start Date
6/30/26
End Date
Funding Split
$34.3K
Federal Obligation
$0.0
Non-Federal Obligation
$34.3K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
R13HL179935
SAI Number
R13HL179935-1493425300
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Funding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Awardee UEI
XL5ANMKWN557
Awardee CAGE
1LBQ2
Performance District
RI-02
Senators
Sheldon Whitehouse
John Reed
John Reed
Modified: 7/25/25